ML22334A046

M221206: Agenda - Meeting with the Advisory Committee on the Medical Uses of Isotopes

ML22334A046
Person / Time
Issue date:	12/06/2022
From:	NRC/OCM
To:
Shared Package
ML22293A439	List: ML22333B030 ML22334A046 ML22348A040
References
M221206
Download: ML22334A046 (2)

Text

AGENDA

Title:

MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES (Public Meeting)

Purpose:

Provide an opportunity to hear views from the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of regulatory interest.

Scheduled:

December 6, 2022 10:00 am Duration:

Approx. 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br /> Location:

Commissioners Conference Room, 1st fl OWFN

Participants:

Presentation ACMUI Panel 60 mins.*

Darlene Metter, M.D., ACMUI Chair Topic:

• Overview of ACMUI activities Michael OHara, Ph.D., ACMUI Food and Drug Administration Representative Topic:

• ACMUIs Review of Yttrium-90 Medical Events Hossein Jadvar, M.D., Ph.D., ACMUI Nuclear Medicine Physician Topics:

• Emerging Radiopharmaceuticals in an Expanding Nuclear Medicine Arena

• Impacts of the American Board of Radiologys Request to Terminate NRC Recognition of the American Board of Radiologys Board Certification Processes Megan Shober, ACMUI Agreement States Representative Topic:

• ACMUIs Comments on the NRC Staffs Regulatory Basis for the Rulemaking on Emerging Medical Technologies and Rubidium-82 Generators

Commissioners Q & A 50 mins.

Discussion - Wrap-up 5 mins.

• For presentation only and does not include time for Commission Q & As